Trials / Completed
CompletedNCT00735774
Suitability of 11C-ORM-13070 as a PET Tracer
Suitability of 11C-ORM-13070 as a Positron Emission Tomography Tracer; an Open Study in Healthy Males
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the suitability of 11C-ORM-13070 as a positron emission tomography tracer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 11C-ORM-13070 | Single dose of i.v. solution |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2008-08-15
- Last updated
- 2009-11-25
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00735774. Inclusion in this directory is not an endorsement.